3D printing debuts in pharma
- 3D printing may still be in the R&D stage in biopharma—but there have been notable successes developing antibiotic-containing catheters, as in-Pharmatechnologist reports.
- In addition, Dr. Horacio D'Agostino and his team at Louisiana State University have constructed filaments, beads, and stents that contained either antibiotics or chemotherapeutic agents.
- D'Agostino and his team are convinced that 3D printing has "limitless potential" in terms of interventional radiology as it relates to patient care.
Currently Dr. D'Agostino and his team are prototyping products, with the goal of eventually being able to print patient-customized catheters and stents on demand.
- in-Pharma Techologist Pharma moves in to 3D printing with customizable drug delivery devices